Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary L Disis

Showing results (71-80 of 189) with videos related to

Pageof 19
Sort By:
Journal of Clinical Immunology|March 21, 2003
Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvantDouglas G McNeel, Keith L Knutson, Kathy Schiffman, et al.
Journal of Leukocyte Biology|January 19, 2018
TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cellsYushe Dang, Zina J Rutnam, Gregory Dietsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapyHailing Lu, Yi Yang, Ekram Gad, et al.
Blood|April 4, 2002
Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancersMary L Disis, Kristine Rinn, Keith L Knutson, et al.
Molecular Cancer Therapeutics|October 28, 2003
Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunityMary L Disis, Nathalie Scholler, Amber Dahlin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 6, 2022
COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating LymphocytesDenise L Cecil, Ekram A Gad, Lauren R Corulli, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the ArtLisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
Journal of Clinical and Translational Science|June 27, 2017
Scholarly productivity and professional advancement of junior researchers receiving KL2, K23, or K08 awards at a large public research institutionJohn K Amory, Diana K N Louden, Christy McKinney, et al.
NPJ Precision Oncology|April 10, 2019
A plasma protein derived TGFβ signature is a prognostic indicator in triple negative breast cancerHiroyuki Katayama, Peiling Tsou, Makoto Kobayashi, et al.
Biomacromolecules|March 23, 2013
Three-dimensional scaffolds to evaluate tumor associated fibroblast-mediated suppression of breast tumor specific T cellsVy Phan-Lai, Stephen J Florczyk, Forrest M Kievit, et al.
Pageof 19

Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
Journal of Clinical Immunology|March 21, 2003
Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvantDouglas G McNeel, Keith L Knutson, Kathy Schiffman, et al.
Journal of Leukocyte Biology|January 19, 2018
TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cellsYushe Dang, Zina J Rutnam, Gregory Dietsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapyHailing Lu, Yi Yang, Ekram Gad, et al.
Blood|April 4, 2002
Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancersMary L Disis, Kristine Rinn, Keith L Knutson, et al.
Molecular Cancer Therapeutics|October 28, 2003
Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunityMary L Disis, Nathalie Scholler, Amber Dahlin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 6, 2022
COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating LymphocytesDenise L Cecil, Ekram A Gad, Lauren R Corulli, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the ArtLisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
Journal of Clinical and Translational Science|June 27, 2017
Scholarly productivity and professional advancement of junior researchers receiving KL2, K23, or K08 awards at a large public research institutionJohn K Amory, Diana K N Louden, Christy McKinney, et al.
NPJ Precision Oncology|April 10, 2019
A plasma protein derived TGFβ signature is a prognostic indicator in triple negative breast cancerHiroyuki Katayama, Peiling Tsou, Makoto Kobayashi, et al.
Biomacromolecules|March 23, 2013
Three-dimensional scaffolds to evaluate tumor associated fibroblast-mediated suppression of breast tumor specific T cellsVy Phan-Lai, Stephen J Florczyk, Forrest M Kievit, et al.
Pageof 19